Section Arrow
PASG.NASDAQ
- Passage Bio Inc
Quotes are at least 15-min delayed:2026/06/04 14:45 EDT
Regular Hours
Last
 5.8561
-0.1139 (-1.91%)
Day High 
6.03 
Prev. Close
5.97 
1-M High
Volume 
17.35K 
Bid
5.72
Ask
5.92
Day Low
5.5426 
Open
5.92 
1-M Low
3.935 
Market Cap 
19.15M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.59 
20-SMA 5.2 
50-SMA 6.63 
52-W High 20 
52-W Low 0.375 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.84/-11.50
Enterprise Value
39.59M
Balance Sheet
Book Value Per Share
3.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VERUVeru Inc4.8712+2.6212+116.50%-- 
RXRXRecursion Pharmaceuticals3.845+0.375+10.81%-- 
INDPIndaptus Therapeutics Inc3.71+1.5+67.87%-- 
IOVAIovance Biotherapeutics4.41+0.62+16.36%-- 
AIMAIM ImmunoTech Inc.0.615-0.117-15.98%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.